Guidelines for the long-term care of pediatric liver transplantation have been published (Liver Transplantation 2013; 19: 798-625). At the time of this writing, it has not been uploaded to the AASLD website which archives a large number of guidelines related to liver disorders (AASLD: Practice Guidelines).
Due to the extensive nature of the guidelines, I will not try to summarize them, though I think having this reference is useful. To see how familiar you are with current recommendations, you may want to take the following quiz:
1. Which of the following are not part of routine liver transplantation care, according to the authors?
- a. Assessment of school functioning
- b. Assessment for hearing loss
- c. Protocol liver biopsy at 1 year
- d. Resumption of full physical activity by 12 weeks after LT
2. Which of these vaccines should be given (if age appropriate) before LT but not afterwards?
- a. Measles, Mumps, Rubella
- b. Varicella
- c. Rotavirus
- d. Human papillomavirus
3. True/False: Tattoos and piercings are acceptable if the child has received the hepatitis B vaccine.
4. Options for treating chronic rejection, which is a major cause of late graft loss, include all of the following except:
- a. Give rituximab
- b. Switch to mycophenolate
- c. Switch to rapamycin
- d. Higher doses of tacrolimus
5. Target level for tacrolimus trough for patients more than 1 year after transplantation?
- a. 10-12 ng/mL
- b. <10 ng/mL
- c. 8-10 ng/mL
- d. <8 ng/mL
- e. <6 ng/mL
6. True statements regarding cytomegalovirus infection include all of the following except
- a. Prophylactic intravenous ganciclovir is indicated for CMV donor-positive/recipient negative but not for CMV donor-negative/recipient-negative
- b. Second-line treatments include foscarnet, acyclovir, and cidofovir
- c. Genotypic testing for mutations can be done to determine if CMV is resistant to ganciclovir
- d. Ganciclovir resistance should be considered in patients with rising CMV loads despite at least 14 days of therapy
7. Minimal recommended time for Pneumocystis jirovecii prophylaxis, according to the authors:
- a. 0 months
- b. 3 months
- c. 6 months
- d. 12 months
- e. 3 years
Answers:
1. C, 2. D, 3. True, 4. A, 5. E, 6. B, 7. C
Related blog posts:
Pingback: Growth after Liver Transplantation | gutsandgrowth
Pingback: AASLD/NASPGHAN 2014 Guidelines for Evaluation of Pediatric Liver Transplantation | gutsandgrowth
Pingback: Subclinical Liver Transplant Rejection | gutsandgrowth